Shares of Rite Aid (NYSE:RAD) moved higher by 6.8% in pre-market trading after the company reported Q1 results.
Earnings per share were up 71.43% over the past year to ($0.04), which beat the estimate of ($0.38).
Revenue of $6,027,000,000 higher by 12.17% from the same period last year, which beat the estimate of $5,610,000,000.
Rite Aid hasn't issued any earnings guidance for the time being.
Rite Aid hasn't issued any revenue guidance for the time being.
How To Listen To The Conference Call
Date: Jun 25, 2020
Time: 08:30 AM
52-week high: $23.88
Company's 52-week low was at $5.04
Price action over last quarter: Up 11.98%
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal-care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.